The Union Health Ministry and ICMR have jointly released revised clinical guidance for the management of adult Covid-19 patients according to which drugs Azithromycin, Favipiravir, and Ivermectin have been banned for symptomatic management of mild infection. These medicines were being blatantly used by many doctors resulting in serious side effects in Covid patients. The guidelines came days after a group of doctors wrote to the Government expressing concern over the unwarranted testing, medication, and hospitalisation.